JYOTHYLAB - Investment Analysis: Buy Signal or Bull Trap?
Back to ListInvestment Rating: 4.1
| Stock Code | JYOTHYLAB | Market Cap | 9,700 Cr. | Current Price | 265 ₹ | High / Low | 378 ₹ |
| Stock P/E | 29.1 | Book Value | 43.3 ₹ | Dividend Yield | 1.32 % | ROCE | 29.6 % |
| ROE | 22.4 % | Face Value | 1.00 ₹ | DMA 50 | 242 ₹ | DMA 200 | 281 ₹ |
| Chg in FII Hold | -0.42 % | Chg in DII Hold | -0.52 % | PAT Qtr | 67.5 Cr. | PAT Prev Qtr | 81.1 Cr. |
| RSI | 67.5 | MACD | 11.5 | Volume | 16,66,918 | Avg Vol 1Wk | 14,41,666 |
| Low price | 196 ₹ | High price | 378 ₹ | PEG Ratio | 1.95 | Debt to equity | 0.03 |
| 52w Index | 37.8 % | Qtr Profit Var | -15.2 % | EPS | 9.07 ₹ | Industry PE | 30.3 |
📊 Jyothy Labs (JYOTHYLAB) shows strong fundamentals with ROCE (29.6%) and ROE (22.4%), reflecting efficient capital use. The P/E (29.1) is slightly below industry average (30.3), suggesting fair valuation. Dividend yield (1.32%) adds income appeal, while debt-to-equity (0.03) highlights financial stability. However, PEG ratio (1.95) indicates the stock is priced at a premium relative to growth. Technical indicators (RSI 67.5, MACD 11.5) suggest bullish momentum but nearing overbought levels.
💡 Ideal Entry Price Zone: ₹240 – ₹255, aligning with 50 DMA (₹242) and offering a margin of safety.
📈 Exit Strategy / Holding Period: For existing holders, maintain a long-term horizon (3–5 years) given strong ROE/ROCE and low debt. Consider partial profit booking near ₹360–₹370 (close to 52-week high). Long-term investors can hold until growth metrics weaken or valuations become stretched beyond industry averages.
✅ Positive
- High ROCE (29.6%) and ROE (22.4%) show strong efficiency.
- Dividend yield (1.32%) provides steady income.
- Low debt-to-equity (0.03) ensures financial stability.
- P/E (29.1) is slightly below industry average, indicating fair valuation.
⚠️ Limitation
- PEG ratio (1.95) suggests premium valuation relative to growth.
- Quarterly profit decline (-15.2%) shows earnings volatility.
- RSI (67.5) indicates near overbought levels.
📉 Company Negative News
- Decline in FII holdings (-0.42%) and DII holdings (-0.52%) shows reduced institutional confidence.
- PAT dropped from ₹81.1 Cr to ₹67.5 Cr, reflecting short-term weakness.
📈 Company Positive News
- Strong ROCE and ROE metrics highlight operational efficiency.
- Healthy trading volumes (16.6 lakh vs avg 14.4 lakh) show investor interest.
🏭 Industry
- Industry P/E at 30.3, slightly higher than JYOTHYLAB’s 29.1, showing sector-wide premium valuations.
- Consumer goods sector outlook remains positive, supporting long-term growth.
📝 Conclusion
Jyothy Labs is a strong candidate for long-term investment, backed by high ROE/ROCE, low debt, and fair valuation. Entry near ₹240–₹255 offers safety, while long-term holding (3–5 years) is recommended. Exit or partial profit booking should be considered near ₹360–₹370. Conservative investors may wait for lower valuations before entering.